Source link : https://www.newshealth.biz/health-news/tapinarof-cream-for-adult-pediatric-eczema-under-fda-review/
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment of atopic dermatitis in adults and children aged ≥ 2 years, according to an announcement by the manufacturer, Dermavant Sciences. Tapinarof cream, 1% (VTAMA) is a steroid-free aryl hydrocarbon […]
Author : News Health
Publish date : 2024-04-30 07:39:05
Copyright for syndicated content belongs to the linked Source.